Published 4 days ago • loading... • Updated 3 days ago

FDA Clears Bolt Medical’s IVL System, Backing Boston Scientific’s $664m Buyout

Summary by Plato. Vertical Search. Ai. | PlatoAiStream. Data Intelligence. Vertical Search. Ai.

Earlier this year, Boston Scientific agreed to acquire a remaining 74% stake in Bolt Medical. Image credit: Shutterstock/Michael Vi. Boston Scientific’s $664m bet on Bolt Medical has paid off, as the company’s intravascular lithotripsy (IVL) system gains US Food and Drug Administration (FDA) clearance. Whilst neither Bolt Medical nor Boston Scientific have publicly unveiled the clearance, the FDA’s database lists a 510(k) decision date of 25th M…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

All

Left

Center

Right

medicaleconomics.com

Boston Scientific closes Bolt Medical acquisition, bolsters intravascular lithotripsy portfolio

Under the terms, Boston Scientific will pay about $443 million upfront, plus up to $221 million if regulatory milestones occur.

3 days ago

Read Full Article

Finance & Commerce

Boston Scientific expansion nears construction, up for DEED award

Boston Scientific plans to break ground soon on a major expansion in Maple Grove, a project that’s up for $1.66 million in awards from the state's Job Creation Fund.

4 days ago

Read Full Article

Medical Device Network

FDA clears Bolt Medical’s IVL system, backing Boston Scientific’s $664m buyout

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.The post FDA clears Bolt Medical’s IVL system, backing Boston Scientific’s $664m buyout appeared first on Medical Device Network.

4 days ago

Read Full Article